Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis
Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells (MSCs) can partially restore the ovarian structure and function damaged by chemotherapy. miR-21 is a microRNA that can regulate cell apoptosis. This st...
Saved in:
Published in | Stem cell research & therapy Vol. 8; no. 1; pp. 187 - 13 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
14.08.2017
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells (MSCs) can partially restore the ovarian structure and function damaged by chemotherapy. miR-21 is a microRNA that can regulate cell apoptosis. This study discusses the repair effect and mechanism of MSCs overexpressing miR-21 on chemotherapy-induced POF.
Rat MSCs and granulosa cells (GCs) were isolated in vitro. MSCs were transfected with miR-21 lentiviral vector (LV-miR-21) to obtain MSCs stably expressing miR-21 (miR-21-MSCs). The microenvironment of an ovary receiving chemotherapy was mimicked by adding phosphamide mustard (PM) into the cellular culture medium. The apoptosis rate and the mRNA and protein expression of target genes PTEN and PDCD4 were detected in MSCs. Apoptosis was induced by adding PM into the culture medium for GCs, which were cocultured with miR-21-MSCs. The apoptosis rate and the mRNA and protein expression of PTEN and PDCD4 were detected. The chemotherapy-induced POF model was built into rats by intraperitoneal cyclophosphamide injection. miR-21-MSCs were transplanted into the bilateral ovary. The rats were sacrificed at 15, 30, 45, and 60 days after the last injection. The ovarian weights, follicle count, estrous cycle, and sex hormone levels (estradiol (E2) and follicle-stimulating hormone (FSH)) were detected. Apoptosis of GCs was determined by TUNEL assay. The miR-21 and mRNA and protein expression of PTEN and PDCD4 were determined.
The apoptosis decreased in MSCs transfected with miR-21. The mRNA and protein expression of target genes PTEN and PDCD4 was downregulated. GCs cocultured with miR-21-MSCs showed a decreased apoptosis, an upregulation of miR-21, and a downregulation of PTEN and PDCD4. Following the injection of miR-21-MSCs, the ovarian weight and follicle counts increased; E
levels increased while FSH levels decreased, with less severe apoptosis of GCs. The miR-21 expression in the ovaries was upregulated, while the mRNA expression and protein expression of PTEN and PDCD4 were downregulated.
Overexpression of miR-21 in MSCs promoted efficacy against chemotherapy-induced POF and its improvement of the repair effect was related to the inhibition of GC apoptosis by targeting PTEN and PDCD4. |
---|---|
AbstractList | Abstract Background Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells (MSCs) can partially restore the ovarian structure and function damaged by chemotherapy. miR-21 is a microRNA that can regulate cell apoptosis. This study discusses the repair effect and mechanism of MSCs overexpressing miR-21 on chemotherapy-induced POF. Methods Rat MSCs and granulosa cells (GCs) were isolated in vitro. MSCs were transfected with miR-21 lentiviral vector (LV-miR-21) to obtain MSCs stably expressing miR-21 (miR-21-MSCs). The microenvironment of an ovary receiving chemotherapy was mimicked by adding phosphamide mustard (PM) into the cellular culture medium. The apoptosis rate and the mRNA and protein expression of target genes PTEN and PDCD4 were detected in MSCs. Apoptosis was induced by adding PM into the culture medium for GCs, which were cocultured with miR-21-MSCs. The apoptosis rate and the mRNA and protein expression of PTEN and PDCD4 were detected. The chemotherapy-induced POF model was built into rats by intraperitoneal cyclophosphamide injection. miR-21-MSCs were transplanted into the bilateral ovary. The rats were sacrificed at 15, 30, 45, and 60 days after the last injection. The ovarian weights, follicle count, estrous cycle, and sex hormone levels (estradiol (E2) and follicle-stimulating hormone (FSH)) were detected. Apoptosis of GCs was determined by TUNEL assay. The miR-21 and mRNA and protein expression of PTEN and PDCD4 were determined. Results The apoptosis decreased in MSCs transfected with miR-21. The mRNA and protein expression of target genes PTEN and PDCD4 was downregulated. GCs cocultured with miR-21-MSCs showed a decreased apoptosis, an upregulation of miR-21, and a downregulation of PTEN and PDCD4. Following the injection of miR-21-MSCs, the ovarian weight and follicle counts increased; E2 levels increased while FSH levels decreased, with less severe apoptosis of GCs. The miR-21 expression in the ovaries was upregulated, while the mRNA expression and protein expression of PTEN and PDCD4 were downregulated. Conclusions Overexpression of miR-21 in MSCs promoted efficacy against chemotherapy-induced POF and its improvement of the repair effect was related to the inhibition of GC apoptosis by targeting PTEN and PDCD4. Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells (MSCs) can partially restore the ovarian structure and function damaged by chemotherapy. miR-21 is a microRNA that can regulate cell apoptosis. This study discusses the repair effect and mechanism of MSCs overexpressing miR-21 on chemotherapy-induced POF. Rat MSCs and granulosa cells (GCs) were isolated in vitro. MSCs were transfected with miR-21 lentiviral vector (LV-miR-21) to obtain MSCs stably expressing miR-21 (miR-21-MSCs). The microenvironment of an ovary receiving chemotherapy was mimicked by adding phosphamide mustard (PM) into the cellular culture medium. The apoptosis rate and the mRNA and protein expression of target genes PTEN and PDCD4 were detected in MSCs. Apoptosis was induced by adding PM into the culture medium for GCs, which were cocultured with miR-21-MSCs. The apoptosis rate and the mRNA and protein expression of PTEN and PDCD4 were detected. The chemotherapy-induced POF model was built into rats by intraperitoneal cyclophosphamide injection. miR-21-MSCs were transplanted into the bilateral ovary. The rats were sacrificed at 15, 30, 45, and 60 days after the last injection. The ovarian weights, follicle count, estrous cycle, and sex hormone levels (estradiol (E2) and follicle-stimulating hormone (FSH)) were detected. Apoptosis of GCs was determined by TUNEL assay. The miR-21 and mRNA and protein expression of PTEN and PDCD4 were determined. The apoptosis decreased in MSCs transfected with miR-21. The mRNA and protein expression of target genes PTEN and PDCD4 was downregulated. GCs cocultured with miR-21-MSCs showed a decreased apoptosis, an upregulation of miR-21, and a downregulation of PTEN and PDCD4. Following the injection of miR-21-MSCs, the ovarian weight and follicle counts increased; E levels increased while FSH levels decreased, with less severe apoptosis of GCs. The miR-21 expression in the ovaries was upregulated, while the mRNA expression and protein expression of PTEN and PDCD4 were downregulated. Overexpression of miR-21 in MSCs promoted efficacy against chemotherapy-induced POF and its improvement of the repair effect was related to the inhibition of GC apoptosis by targeting PTEN and PDCD4. Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells (MSCs) can partially restore the ovarian structure and function damaged by chemotherapy. miR-21 is a microRNA that can regulate cell apoptosis. This study discusses the repair effect and mechanism of MSCs overexpressing miR-21 on chemotherapy-induced POF.BACKGROUNDChemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells (MSCs) can partially restore the ovarian structure and function damaged by chemotherapy. miR-21 is a microRNA that can regulate cell apoptosis. This study discusses the repair effect and mechanism of MSCs overexpressing miR-21 on chemotherapy-induced POF.Rat MSCs and granulosa cells (GCs) were isolated in vitro. MSCs were transfected with miR-21 lentiviral vector (LV-miR-21) to obtain MSCs stably expressing miR-21 (miR-21-MSCs). The microenvironment of an ovary receiving chemotherapy was mimicked by adding phosphamide mustard (PM) into the cellular culture medium. The apoptosis rate and the mRNA and protein expression of target genes PTEN and PDCD4 were detected in MSCs. Apoptosis was induced by adding PM into the culture medium for GCs, which were cocultured with miR-21-MSCs. The apoptosis rate and the mRNA and protein expression of PTEN and PDCD4 were detected. The chemotherapy-induced POF model was built into rats by intraperitoneal cyclophosphamide injection. miR-21-MSCs were transplanted into the bilateral ovary. The rats were sacrificed at 15, 30, 45, and 60 days after the last injection. The ovarian weights, follicle count, estrous cycle, and sex hormone levels (estradiol (E2) and follicle-stimulating hormone (FSH)) were detected. Apoptosis of GCs was determined by TUNEL assay. The miR-21 and mRNA and protein expression of PTEN and PDCD4 were determined.METHODSRat MSCs and granulosa cells (GCs) were isolated in vitro. MSCs were transfected with miR-21 lentiviral vector (LV-miR-21) to obtain MSCs stably expressing miR-21 (miR-21-MSCs). The microenvironment of an ovary receiving chemotherapy was mimicked by adding phosphamide mustard (PM) into the cellular culture medium. The apoptosis rate and the mRNA and protein expression of target genes PTEN and PDCD4 were detected in MSCs. Apoptosis was induced by adding PM into the culture medium for GCs, which were cocultured with miR-21-MSCs. The apoptosis rate and the mRNA and protein expression of PTEN and PDCD4 were detected. The chemotherapy-induced POF model was built into rats by intraperitoneal cyclophosphamide injection. miR-21-MSCs were transplanted into the bilateral ovary. The rats were sacrificed at 15, 30, 45, and 60 days after the last injection. The ovarian weights, follicle count, estrous cycle, and sex hormone levels (estradiol (E2) and follicle-stimulating hormone (FSH)) were detected. Apoptosis of GCs was determined by TUNEL assay. The miR-21 and mRNA and protein expression of PTEN and PDCD4 were determined.The apoptosis decreased in MSCs transfected with miR-21. The mRNA and protein expression of target genes PTEN and PDCD4 was downregulated. GCs cocultured with miR-21-MSCs showed a decreased apoptosis, an upregulation of miR-21, and a downregulation of PTEN and PDCD4. Following the injection of miR-21-MSCs, the ovarian weight and follicle counts increased; E2 levels increased while FSH levels decreased, with less severe apoptosis of GCs. The miR-21 expression in the ovaries was upregulated, while the mRNA expression and protein expression of PTEN and PDCD4 were downregulated.RESULTSThe apoptosis decreased in MSCs transfected with miR-21. The mRNA and protein expression of target genes PTEN and PDCD4 was downregulated. GCs cocultured with miR-21-MSCs showed a decreased apoptosis, an upregulation of miR-21, and a downregulation of PTEN and PDCD4. Following the injection of miR-21-MSCs, the ovarian weight and follicle counts increased; E2 levels increased while FSH levels decreased, with less severe apoptosis of GCs. The miR-21 expression in the ovaries was upregulated, while the mRNA expression and protein expression of PTEN and PDCD4 were downregulated.Overexpression of miR-21 in MSCs promoted efficacy against chemotherapy-induced POF and its improvement of the repair effect was related to the inhibition of GC apoptosis by targeting PTEN and PDCD4.CONCLUSIONSOverexpression of miR-21 in MSCs promoted efficacy against chemotherapy-induced POF and its improvement of the repair effect was related to the inhibition of GC apoptosis by targeting PTEN and PDCD4. Background Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells (MSCs) can partially restore the ovarian structure and function damaged by chemotherapy. miR-21 is a microRNA that can regulate cell apoptosis. This study discusses the repair effect and mechanism of MSCs overexpressing miR-21 on chemotherapy-induced POF. Methods Rat MSCs and granulosa cells (GCs) were isolated in vitro. MSCs were transfected with miR-21 lentiviral vector (LV-miR-21) to obtain MSCs stably expressing miR-21 (miR-21-MSCs). The microenvironment of an ovary receiving chemotherapy was mimicked by adding phosphamide mustard (PM) into the cellular culture medium. The apoptosis rate and the mRNA and protein expression of target genes PTEN and PDCD4 were detected in MSCs. Apoptosis was induced by adding PM into the culture medium for GCs, which were cocultured with miR-21-MSCs. The apoptosis rate and the mRNA and protein expression of PTEN and PDCD4 were detected. The chemotherapy-induced POF model was built into rats by intraperitoneal cyclophosphamide injection. miR-21-MSCs were transplanted into the bilateral ovary. The rats were sacrificed at 15, 30, 45, and 60 days after the last injection. The ovarian weights, follicle count, estrous cycle, and sex hormone levels (estradiol (E2) and follicle-stimulating hormone (FSH)) were detected. Apoptosis of GCs was determined by TUNEL assay. The miR-21 and mRNA and protein expression of PTEN and PDCD4 were determined. Results The apoptosis decreased in MSCs transfected with miR-21. The mRNA and protein expression of target genes PTEN and PDCD4 was downregulated. GCs cocultured with miR-21-MSCs showed a decreased apoptosis, an upregulation of miR-21, and a downregulation of PTEN and PDCD4. Following the injection of miR-21-MSCs, the ovarian weight and follicle counts increased; E2 levels increased while FSH levels decreased, with less severe apoptosis of GCs. The miR-21 expression in the ovaries was upregulated, while the mRNA expression and protein expression of PTEN and PDCD4 were downregulated. Conclusions Overexpression of miR-21 in MSCs promoted efficacy against chemotherapy-induced POF and its improvement of the repair effect was related to the inhibition of GC apoptosis by targeting PTEN and PDCD4. |
ArticleNumber | 187 |
Audience | Academic |
Author | Wang, Xuefeng Li, Xinran Chen, Xiaoying He, Yuanli Peng, Dongxian Fu, Xiafei Wang, Qing |
Author_xml | – sequence: 1 givenname: Xiafei orcidid: 0000-0002-0344-7620 surname: Fu fullname: Fu, Xiafei – sequence: 2 givenname: Yuanli surname: He fullname: He, Yuanli – sequence: 3 givenname: Xuefeng surname: Wang fullname: Wang, Xuefeng – sequence: 4 givenname: Dongxian surname: Peng fullname: Peng, Dongxian – sequence: 5 givenname: Xiaoying surname: Chen fullname: Chen, Xiaoying – sequence: 6 givenname: Xinran surname: Li fullname: Li, Xinran – sequence: 7 givenname: Qing surname: Wang fullname: Wang, Qing |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28807003$$D View this record in MEDLINE/PubMed |
BookMark | eNp9k1FP1jAUhhejEUR-gDemiYnRi-G6bt12Y0IAlYQIQbxuuvZ0K9na2XafwJ_zr9nxIfIR45alW_u8b3fe9LxInhprIEle4WwP45p-8JjkdZVmOD60wOnNk2QbV2WV0hLnTx-8byW73l9m8SIki-jzZCuv66yK39vJr9MVOLiaHHivrUFWoVGfpzlG2iAfYEQChsEjPU7OrsAju-JO82XNzSLMDhA3EqnZiLDoo8rx4NFPHXokehht6MHx6TrVRs4C5L2B5CPvALXXKHDXQdCmQ2eHB4fFreHZxdFXFGz063WrA-ocN_NgPb_9H8QnOwXrtX-ZPFN88LB7N-4k3z8dXRx8SU9OPx8f7J-kguZlWHLAhFNcNFUhVEML0lR5VpRE1C2AkkBkRalUXEKmKlFQIQWtMpoLiDFRRXaS47WvtPySTU6P3F0zyzW7nbCuY9wFLQZgsslbzmnWVEoUouUtkYJQKKEWSjYljl4f117T3I4gBZjg-LBhurlidM86u2JlWVJC6mjw7s7A2R8z-MBG7ZdcuAE7e4abvMFZEwuI6JtH6KWdnYlRRYrQvC5I1vylOh4L0EbZuK9YTNl-TC6v84KQSO39g4q3hFGLeDqVjvMbgvcbgsgEuAodn71nx9_ON9m3D9ge-BB6b4d5OVV-E3z9ML372P6c6QjgNSCc9d6BukdwxpbWYevWYbF12NI67CZqqkcaoQNf9o4l6uE_yt_zdh5v |
CitedBy_id | crossref_primary_10_3389_fcell_2023_1090997 crossref_primary_10_1021_cbe_4c00122 crossref_primary_10_1155_2019_9071720 crossref_primary_10_2174_1574888X18666230517123256 crossref_primary_10_1155_2020_3582648 crossref_primary_10_1016_j_reprotox_2022_03_012 crossref_primary_10_1016_j_mce_2020_110875 crossref_primary_10_3390_cells11142253 crossref_primary_10_1186_s40659_023_00441_6 crossref_primary_10_1016_j_ygeno_2024_110856 crossref_primary_10_1080_10495398_2022_2095642 crossref_primary_10_1186_s13048_024_01534_w crossref_primary_10_1093_humupd_dmz039 crossref_primary_10_1016_j_ncrna_2025_03_001 crossref_primary_10_3389_fcell_2021_649005 crossref_primary_10_1038_s41374_019_0273_2 crossref_primary_10_3389_fimmu_2022_997808 crossref_primary_10_3390_genes16020133 crossref_primary_10_2147_DDDT_S321010 crossref_primary_10_3389_fbioe_2022_850303 crossref_primary_10_1186_s13287_021_02529_w crossref_primary_10_1186_s13287_019_1136_x crossref_primary_10_3390_ijms242316593 crossref_primary_10_1007_s00109_021_02055_5 crossref_primary_10_1186_s13287_018_1008_9 crossref_primary_10_3390_biom14020242 crossref_primary_10_1186_s13287_024_03704_5 crossref_primary_10_1016_j_trim_2024_102051 crossref_primary_10_3390_cells11233713 crossref_primary_10_1016_j_heliyon_2023_e23271 crossref_primary_10_1016_j_fertnstert_2024_03_010 crossref_primary_10_1093_biolre_ioac085 crossref_primary_10_1016_j_envpol_2022_119115 crossref_primary_10_1155_2022_9228456 crossref_primary_10_1016_j_reth_2023_11_007 crossref_primary_10_3390_ijms23158276 crossref_primary_10_3389_fmed_2023_1194865 crossref_primary_10_1007_s43032_020_00305_4 crossref_primary_10_1016_j_theriogenology_2024_01_029 crossref_primary_10_1186_s12929_024_01085_8 crossref_primary_10_1002_cbin_11165 crossref_primary_10_1038_s41434_019_0101_8 crossref_primary_10_4252_wjsc_v16_i1_1 crossref_primary_10_1016_j_biopha_2019_109710 crossref_primary_10_1002_mrd_23404 crossref_primary_10_3389_fphar_2022_828627 crossref_primary_10_1016_j_omtn_2019_03_008 crossref_primary_10_1155_2022_7530102 crossref_primary_10_1186_s12958_022_00892_8 crossref_primary_10_3390_ijms26020576 crossref_primary_10_1089_ten_teb_2020_0205 crossref_primary_10_1016_j_biopha_2023_115284 crossref_primary_10_1186_s13287_021_02212_0 crossref_primary_10_1016_j_ando_2023_03_013 crossref_primary_10_3892_mmr_2018_9440 crossref_primary_10_5713_ajas_19_0707 crossref_primary_10_1016_j_anireprosci_2020_106645 crossref_primary_10_1186_s13287_023_03333_4 crossref_primary_10_1016_j_biopha_2023_115319 crossref_primary_10_1016_j_cbi_2022_110176 crossref_primary_10_1016_j_mtbio_2025_101469 crossref_primary_10_1111_boc_202300123 crossref_primary_10_3389_fcell_2021_749822 crossref_primary_10_3390_biology10060464 crossref_primary_10_1093_biolre_ioz077 crossref_primary_10_1016_j_biopha_2018_03_056 crossref_primary_10_1186_s40001_023_01231_2 crossref_primary_10_1016_j_ijbiomac_2023_127415 crossref_primary_10_1016_j_ymthe_2020_02_003 crossref_primary_10_3892_ijmm_2023_5297 crossref_primary_10_1007_s12035_024_04490_0 crossref_primary_10_1186_s13287_020_01988_x crossref_primary_10_1016_j_freeradbiomed_2024_05_048 crossref_primary_10_1186_s11658_025_00701_1 crossref_primary_10_1186_s13287_019_1442_3 crossref_primary_10_1016_j_ijbiomac_2024_134195 crossref_primary_10_1007_s10495_023_01833_5 crossref_primary_10_3389_fnmol_2018_00070 crossref_primary_10_1007_s00404_023_06922_z crossref_primary_10_1007_s00404_023_07062_0 crossref_primary_10_1155_2021_1781532 crossref_primary_10_1186_s12929_021_00749_z crossref_primary_10_1016_j_yexcr_2023_113574 crossref_primary_10_1080_21655979_2022_2062104 crossref_primary_10_7717_peerj_16517 crossref_primary_10_1007_s43032_023_01300_1 crossref_primary_10_1016_j_theriogenology_2023_01_018 crossref_primary_10_1007_s10735_024_10256_8 crossref_primary_10_1016_j_ygcen_2022_114015 crossref_primary_10_1186_s13287_019_1315_9 crossref_primary_10_1016_j_bioactmat_2020_12_008 crossref_primary_10_1007_s12015_024_10681_y crossref_primary_10_3390_ijms241814215 crossref_primary_10_1016_j_biopha_2018_12_123 crossref_primary_10_1186_s13048_020_00671_2 crossref_primary_10_1515_biol_2022_0997 crossref_primary_10_1093_hropen_hoad040 crossref_primary_10_1177_1533033819892263 crossref_primary_10_3390_cells9102253 crossref_primary_10_2174_1574888X17666220511142930 crossref_primary_10_1097_MD_0000000000030013 crossref_primary_10_1016_j_envpol_2023_122730 crossref_primary_10_3390_ani14060884 crossref_primary_10_1016_j_arcmed_2021_01_008 crossref_primary_10_2174_1871530323666230627121700 crossref_primary_10_1186_s13287_023_03374_9 crossref_primary_10_1016_j_bpobgyn_2025_102603 crossref_primary_10_1155_2021_8293699 crossref_primary_10_3389_fphys_2022_998424 crossref_primary_10_1038_s41598_019_45642_w crossref_primary_10_1186_s13287_023_03551_w crossref_primary_10_3390_cells10071613 crossref_primary_10_4252_wjsc_v12_i4_277 crossref_primary_10_1016_j_biomaterials_2022_121739 crossref_primary_10_1186_s13287_022_03056_y crossref_primary_10_1016_j_prp_2023_154795 crossref_primary_10_1155_sci_7674219 crossref_primary_10_1016_j_gendis_2019_09_013 crossref_primary_10_3390_ijms20205223 crossref_primary_10_3389_fcell_2021_718192 crossref_primary_10_1155_2020_8861557 crossref_primary_10_3390_biology12010108 crossref_primary_10_1002_mrd_23457 crossref_primary_10_1186_s13287_018_0964_4 crossref_primary_10_1016_j_cyto_2023_156294 crossref_primary_10_2174_1574888X14666190314123006 crossref_primary_10_14336_AD_2021_1209 crossref_primary_10_4236_jbm_2024_127025 crossref_primary_10_1080_21655979_2022_2070584 crossref_primary_10_1186_s12958_022_00992_5 crossref_primary_10_1093_humupd_dmae020 crossref_primary_10_1186_s13048_024_01353_z crossref_primary_10_1016_j_biopha_2021_112050 crossref_primary_10_1016_j_rbmo_2024_103815 crossref_primary_10_1007_s10142_022_00931_y crossref_primary_10_1016_j_ecoenv_2019_110160 crossref_primary_10_1159_000510943 crossref_primary_10_1155_2022_5413504 |
Cites_doi | 10.3109/13697137.2015.1020484 10.1007/978-1-4614-0332-6_4 10.1095/biolreprod.109.081448 10.1016/j.reprotox.2004.06.002 10.1038/82797 10.3109/09513590.2010.520374 10.1038/sj.onc.1210083 10.1016/j.yjmcc.2008.05.004 10.1016/S0140-6736(05)66879-1 10.1126/science.284.5411.143 10.1080/14653240802035926 10.1038/ni.1828 10.1016/j.jocn.2015.07.029 10.4238/2015.August.3.4 10.1038/modpathol.2010.135 10.2165/00002018-200528050-00004 10.1007/s11033-014-3820-3 10.1016/j.humpath.2014.09.006 10.1177/1933719115576727 10.1016/0041-008X(91)90310-B 10.7150/ijbs.7.762 10.1210/me.2008-0095 10.1158/1078-0432.CCR-07-1598 10.1093/humupd/dmu019 10.4049/jimmunol.177.11.8095 10.1186/s13287-016-0341-0 10.1016/j.mehy.2009.06.023 10.1016/j.jor.2016.10.010 10.1126/science.276.5309.71 10.1016/j.ygyno.2014.01.034 10.1016/j.ogc.2014.10.004 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017 The Author(s). 2017 |
Copyright_xml | – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017 – notice: The Author(s). 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13287-017-0641-z |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1757-6512 |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_d92baa6097fc4cbab3dc36e5e8cfd951 PMC5556338 A511282433 28807003 10_1186_s13287_017_0641_z |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; grantid: 2013B021800145 – fundername: ; grantid: 81300462 |
GroupedDBID | --- 0R~ 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACIHN ACJQM ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION DIK E3Z EBD EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IEA IHR IHW INH INR ISR ITC KQ8 LK8 M1P M7P M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SBL SOJ SV3 TUS UKHRP CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB PMFND 3V. 7XB 8FK AHSBF AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c625t-65113a614974cf96439720453c8beefde3d766dfade0f7c46cdc67062ce0036f3 |
IEDL.DBID | 7X7 |
ISSN | 1757-6512 |
IngestDate | Wed Aug 27 01:08:22 EDT 2025 Thu Aug 21 14:13:34 EDT 2025 Fri Jul 11 01:04:42 EDT 2025 Fri Jul 25 11:58:34 EDT 2025 Tue Jun 17 22:04:58 EDT 2025 Tue Jun 10 21:03:42 EDT 2025 Fri Jun 27 05:32:42 EDT 2025 Thu May 22 21:24:05 EDT 2025 Mon Jul 21 06:02:39 EDT 2025 Tue Jul 01 00:43:18 EDT 2025 Thu Apr 24 22:53:43 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | PDCD4 PTEN Bone marrow derived mesenchymal stem cells miR-21 Chemotherapy-induced premature ovarian failure Apoptosis |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c625t-65113a614974cf96439720453c8beefde3d766dfade0f7c46cdc67062ce0036f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0344-7620 |
OpenAccessLink | https://www.proquest.com/docview/1936284309?pq-origsite=%requestingapplication% |
PMID | 28807003 |
PQID | 1936284309 |
PQPubID | 2040189 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d92baa6097fc4cbab3dc36e5e8cfd951 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5556338 proquest_miscellaneous_1929109670 proquest_journals_1936284309 gale_infotracmisc_A511282433 gale_infotracacademiconefile_A511282433 gale_incontextgauss_ISR_A511282433 gale_healthsolutions_A511282433 pubmed_primary_28807003 crossref_primary_10_1186_s13287_017_0641_z crossref_citationtrail_10_1186_s13287_017_0641_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-08-14 |
PublicationDateYYYYMMDD | 2017-08-14 |
PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-14 day: 14 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Stem cell research & therapy |
PublicationTitleAlternate | Stem Cell Res Ther |
PublicationYear | 2017 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | DR Plowchalk (641_CR13) 1991; 107 H Haider (641_CR20) 2008; 45 K Sriraman (641_CR32) 2015; 22 DJ Prockop (641_CR19) 1997; 276 E Kovanci (641_CR2) 2015; 42 JR Molina (641_CR18) 2005; 28 SC Janga (641_CR8) 2011; 722 FJ Sheedy (641_CR29) 2010; 11 S Wen (641_CR21) 2015; 14 AE Eltorai (641_CR6) 2016; 14 C Lv (641_CR23) 2016; 27 ML Si (641_CR22) 2007; 26 H Roness (641_CR17) 2014; 20 A Singh (641_CR5) 2016; 7 CL Benetti-Pinto (641_CR1) 2011; 27 HY Fan (641_CR25) 2008; 22 SA Rao (641_CR28) 2010; 23 PJ Devine (641_CR14) 2004; 19 JK Chan (641_CR9) 2014; 132 L Arbibe (641_CR30) 2000; 1 Y Nie (641_CR24) 2011; 7 H Kuang (641_CR27) 2009; 73 A Hilliard (641_CR31) 2006; 177 SS Faubion (641_CR3) 2015; 18 X Fu (641_CR7) 2008; 10 C Shang (641_CR10) 2015; 42 MF Pittenger (641_CR15) 1999; 284 A Vats (641_CR4) 2005; 366 G Pennelli (641_CR11) 2015; 46 MZ Carletti (641_CR12) 2010; 83 L Cox (641_CR16) 2014; 6 NN Danial (641_CR26) 2007; 13 27821993 - J Orthop. 2016 Oct 25;14 (1):1-3 9082988 - Science. 1997 Apr 4;276(5309):71-4 16099296 - Lancet. 2005 Aug 13-19;366(9485):592-602 21698002 - Int J Biol Sci. 2011;7(6):762-8 21214499 - Gynecol Endocrinol. 2011 Sep;27(9):645-9 27259550 - Stem Cell Res Ther. 2016 Jun 04;7(1):82 24591848 - Int J Womens Health. 2014 Feb 20;6:235-43 20357270 - Biol Reprod. 2010 Aug 1;83(2):286-95 25316501 - Hum Pathol. 2015 Jan;46(1):50-7 19733443 - Med Hypotheses. 2009 Dec;73(6):961-2 21915782 - Adv Exp Med Biol. 2011;722:59-74 11101877 - Nat Immunol. 2000 Dec;1(6):533-40 17114484 - J Immunol. 2006 Dec 1;177(11):8095-102 18561945 - J Mol Cell Cardiol. 2008 Oct;45(4):554-66 24472409 - Gynecol Oncol. 2014 Mar;132(3):739-44 2000634 - Toxicol Appl Pharmacol. 1991 Mar 1;107(3):472-81 15853442 - Drug Saf. 2005;28(5):401-16 20711171 - Mod Pathol. 2010 Oct;23(10):1404-17 25845383 - Climacteric. 2015;18(4):483-91 25394756 - Mol Biol Rep. 2015 Mar;42(3):721-7 25681846 - Obstet Gynecol Clin North Am. 2015 Mar;42(1):153-61 26810470 - J Clin Neurosci. 2016 May;27:154-60 25779995 - Reprod Sci. 2015 Jul;22(7):884-903 15336714 - Reprod Toxicol. 2004 Nov;19(1):71-7 18094405 - Clin Cancer Res. 2007 Dec 15;13(24):7254-63 10102814 - Science. 1999 Apr 2;284(5411):143-7 18606860 - Mol Endocrinol. 2008 Sep;22(9):2128-40 26345812 - Genet Mol Res. 2015 Aug 03;14 (3):8810-8 18574768 - Cytotherapy. 2008;10(4):353-63 17072344 - Oncogene. 2007 Apr 26;26(19):2799-803 24833728 - Hum Reprod Update. 2014 Sep-Oct;20(5):759-74 19946272 - Nat Immunol. 2010 Feb;11(2):141-7 |
References_xml | – volume: 18 start-page: 483 year: 2015 ident: 641_CR3 publication-title: Climacteric doi: 10.3109/13697137.2015.1020484 – volume: 722 start-page: 59 year: 2011 ident: 641_CR8 publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4614-0332-6_4 – volume: 83 start-page: 286 year: 2010 ident: 641_CR12 publication-title: Biol Reprod doi: 10.1095/biolreprod.109.081448 – volume: 19 start-page: 71 year: 2004 ident: 641_CR14 publication-title: Reprod Toxicol doi: 10.1016/j.reprotox.2004.06.002 – volume: 1 start-page: 533 year: 2000 ident: 641_CR30 publication-title: Nat Immunol doi: 10.1038/82797 – volume: 27 start-page: 645 year: 2011 ident: 641_CR1 publication-title: Gynecol Endocrinol doi: 10.3109/09513590.2010.520374 – volume: 26 start-page: 2799 year: 2007 ident: 641_CR22 publication-title: Oncogene doi: 10.1038/sj.onc.1210083 – volume: 45 start-page: 554 year: 2008 ident: 641_CR20 publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2008.05.004 – volume: 366 start-page: 592 year: 2005 ident: 641_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(05)66879-1 – volume: 284 start-page: 143 year: 1999 ident: 641_CR15 publication-title: Science doi: 10.1126/science.284.5411.143 – volume: 10 start-page: 353 year: 2008 ident: 641_CR7 publication-title: Cytotherapy doi: 10.1080/14653240802035926 – volume: 11 start-page: 141 year: 2010 ident: 641_CR29 publication-title: Nat Immunol doi: 10.1038/ni.1828 – volume: 27 start-page: 154 year: 2016 ident: 641_CR23 publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2015.07.029 – volume: 14 start-page: 8810 year: 2015 ident: 641_CR21 publication-title: Genet Mol Res. doi: 10.4238/2015.August.3.4 – volume: 23 start-page: 1404 year: 2010 ident: 641_CR28 publication-title: Mod Pathol doi: 10.1038/modpathol.2010.135 – volume: 28 start-page: 401 year: 2005 ident: 641_CR18 publication-title: Drug Saf doi: 10.2165/00002018-200528050-00004 – volume: 42 start-page: 721 year: 2015 ident: 641_CR10 publication-title: Mol Biol Rep doi: 10.1007/s11033-014-3820-3 – volume: 6 start-page: 235 year: 2014 ident: 641_CR16 publication-title: Int J Womens Health – volume: 46 start-page: 50 year: 2015 ident: 641_CR11 publication-title: Hum Pathol doi: 10.1016/j.humpath.2014.09.006 – volume: 22 start-page: 884 year: 2015 ident: 641_CR32 publication-title: Reprod Sci doi: 10.1177/1933719115576727 – volume: 107 start-page: 472 year: 1991 ident: 641_CR13 publication-title: Toxicol Appl Pharmacol doi: 10.1016/0041-008X(91)90310-B – volume: 7 start-page: 762 year: 2011 ident: 641_CR24 publication-title: Int J Biol Sci doi: 10.7150/ijbs.7.762 – volume: 22 start-page: 2128 year: 2008 ident: 641_CR25 publication-title: Mol Endocrinol doi: 10.1210/me.2008-0095 – volume: 13 start-page: 7254 year: 2007 ident: 641_CR26 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-1598 – volume: 20 start-page: 759 year: 2014 ident: 641_CR17 publication-title: Hum Reprod Update doi: 10.1093/humupd/dmu019 – volume: 177 start-page: 8095 year: 2006 ident: 641_CR31 publication-title: Immunol doi: 10.4049/jimmunol.177.11.8095 – volume: 7 start-page: 82 year: 2016 ident: 641_CR5 publication-title: Stem Cell Res Ther doi: 10.1186/s13287-016-0341-0 – volume: 73 start-page: 961 year: 2009 ident: 641_CR27 publication-title: Med Hypotheses doi: 10.1016/j.mehy.2009.06.023 – volume: 14 start-page: 1 year: 2016 ident: 641_CR6 publication-title: J Orthop doi: 10.1016/j.jor.2016.10.010 – volume: 276 start-page: 71 year: 1997 ident: 641_CR19 publication-title: Science doi: 10.1126/science.276.5309.71 – volume: 132 start-page: 739 year: 2014 ident: 641_CR9 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.01.034 – volume: 42 start-page: 153 year: 2015 ident: 641_CR2 publication-title: Obstet Gynecol Clin North Am doi: 10.1016/j.ogc.2014.10.004 – reference: 18574768 - Cytotherapy. 2008;10(4):353-63 – reference: 19946272 - Nat Immunol. 2010 Feb;11(2):141-7 – reference: 26810470 - J Clin Neurosci. 2016 May;27:154-60 – reference: 21698002 - Int J Biol Sci. 2011;7(6):762-8 – reference: 15853442 - Drug Saf. 2005;28(5):401-16 – reference: 25845383 - Climacteric. 2015;18(4):483-91 – reference: 21214499 - Gynecol Endocrinol. 2011 Sep;27(9):645-9 – reference: 20711171 - Mod Pathol. 2010 Oct;23(10):1404-17 – reference: 25779995 - Reprod Sci. 2015 Jul;22(7):884-903 – reference: 17072344 - Oncogene. 2007 Apr 26;26(19):2799-803 – reference: 17114484 - J Immunol. 2006 Dec 1;177(11):8095-102 – reference: 25681846 - Obstet Gynecol Clin North Am. 2015 Mar;42(1):153-61 – reference: 10102814 - Science. 1999 Apr 2;284(5411):143-7 – reference: 24833728 - Hum Reprod Update. 2014 Sep-Oct;20(5):759-74 – reference: 18094405 - Clin Cancer Res. 2007 Dec 15;13(24):7254-63 – reference: 15336714 - Reprod Toxicol. 2004 Nov;19(1):71-7 – reference: 27821993 - J Orthop. 2016 Oct 25;14 (1):1-3 – reference: 24591848 - Int J Womens Health. 2014 Feb 20;6:235-43 – reference: 26345812 - Genet Mol Res. 2015 Aug 03;14 (3):8810-8 – reference: 2000634 - Toxicol Appl Pharmacol. 1991 Mar 1;107(3):472-81 – reference: 20357270 - Biol Reprod. 2010 Aug 1;83(2):286-95 – reference: 18606860 - Mol Endocrinol. 2008 Sep;22(9):2128-40 – reference: 16099296 - Lancet. 2005 Aug 13-19;366(9485):592-602 – reference: 24472409 - Gynecol Oncol. 2014 Mar;132(3):739-44 – reference: 11101877 - Nat Immunol. 2000 Dec;1(6):533-40 – reference: 18561945 - J Mol Cell Cardiol. 2008 Oct;45(4):554-66 – reference: 27259550 - Stem Cell Res Ther. 2016 Jun 04;7(1):82 – reference: 9082988 - Science. 1997 Apr 4;276(5309):71-4 – reference: 21915782 - Adv Exp Med Biol. 2011;722:59-74 – reference: 25394756 - Mol Biol Rep. 2015 Mar;42(3):721-7 – reference: 19733443 - Med Hypotheses. 2009 Dec;73(6):961-2 – reference: 25316501 - Hum Pathol. 2015 Jan;46(1):50-7 |
SSID | ssj0000330064 |
Score | 2.5078113 |
Snippet | Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells (MSCs) can... Background Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal stem cells... Abstract Background Chemotherapy-induced premature ovarian failure (POF) is a severe complication affecting tumor patients at a childbearing age. Mesenchymal... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 187 |
SubjectTerms | 17β-Estradiol Animals Antineoplastic Agents - adverse effects Apoptosis Apoptosis Regulatory Proteins - metabolism Bone marrow Bone marrow derived mesenchymal stem cells Care and treatment Cell culture Cells, Cultured Chemotherapy Chemotherapy-induced premature ovarian failure Cyclophosphamide Development and progression Estrus cycle Female Follicle-stimulating hormone Gene expression Genetic aspects Genetic Vectors - metabolism Gonadal Steroid Hormones - metabolism Granulosa cells Granulosa Cells - metabolism Granulosa Cells - pathology Health aspects Injection Laboratory animals Lentivirus - metabolism Medical research Mesenchymal stem cells Mesenchymal Stromal Cells - metabolism Mesenchyme MicroRNA MicroRNAs MicroRNAs - genetics MicroRNAs - metabolism miR-21 miRNA Organ Size Ovarian cancer Ovarian diseases Ovaries Ovary - pathology Patient outcomes PDCD4 PTEN PTEN Phosphohydrolase - metabolism PTEN protein R&D Rats, Wistar Reproductive status Research & development RNA, Messenger - genetics RNA, Messenger - metabolism Rodents Stem cell transplantation Stem cells Stem Cells - metabolism Structure-function relationships Transfection Transplantation |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ba9VAEF6kIPgi3k2tuoogCKE5yWaz-1h7oQrWUlvo27LXNtCTFHOOePrn_GvObNJwgqAvvmZnl2Rmdi6bmW8JeZdbLcBR-9RklU2ZC1kqHJ7EmVwaVurAY4f3lyN-eMY-n5fna1d9YU1YDw_cM27bydxozTNZBcus0aZwtuC-9MIGJ2PzdA4-by2ZijYY0nRwtsNvzJng2x2kXQKrLLHai83Sm4kjinj9f1rlNbc0LZlc80EHD8j9IXikO_1LPyR3fPOI3O2vk1w9Jr--gl76n0Npa0PbQOf1SZrPaN1QBGymeEzf0ToeJPiOtj8gU9Y4hiCyy--e6sZRdHUoLpwF-tFRPKulINz50K21SiGRB5Vw4wJOz8EuUbOifWU5-EN6vLe7x-KCx6f7R3TRwnqXtakX9AL84_Kq7XR8H6qv2-tF29XdE3J2sH-6e5gOFzSkFtKmRcohWis0OHhISmyQMbhBePvCCuN9cL5wFecuaOezUFnGrbO8ynhuPeLghOIp2Wjaxj8nVBpROsmdLBjENExrF6wrhbTSekgxfUKyW2kpO6CX4yUaVypmMYKrXsAKBKxQwOomIR_GKdc9dMffiD-iCoyEiLodH4AuqkEX1b90MSGvUYFU38I62g61g1GtyFlRJORtpEDkjQZLey70suvUp28nE6L3A1Fo4RutHjolgFMI1jWh3JpQgmmw0-FbTVaDaeoUROwcYpIikwl5Mw7jTCy3a3y7RJocwkgJskrIs17xR87kYPErEF9CqsmWmLBuOtLUlxG4vEQ0ukJs_g9evyD38riZRTpjW2QDNop_CfHhwryKpuA3uzhnQg priority: 102 providerName: Directory of Open Access Journals |
Title | Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28807003 https://www.proquest.com/docview/1936284309 https://www.proquest.com/docview/1929109670 https://pubmed.ncbi.nlm.nih.gov/PMC5556338 https://doaj.org/article/d92baa6097fc4cbab3dc36e5e8cfd951 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgExIviDuBUQxCQkKKlubiJE9o3ToNJEpVNmnixXJ86SKtSVlaRPfn-Guc47hhEdJe-lAfW4nP_eT4MyHvQykycNTaL4JU-rEygZ8prMQVYV7EiTDMnvD-OmEnZ_GX8-TcFdwa11a5tYnWUKtaYo18HwINBqY0CvJPy58-3hqFX1fdFRp3yS5Cl6FUp-dpV2MJIFkHl-s-Zg4ztt9A8pVhryX2fMVD_7rnjixq__-2-YZz6jdO3vBExw_JAxdC0oOW54_IHV09JvfaSyU3T8ifbyCd-rdrcK1obeiinPnhkJYVRdhmisX6hpa2nKAbWv-CfFngGELJrq80FZWi6PCQaTgLpKShWLGlwOKFO7O18SGdB8FQ3QJKLMA60WJD2_5y8Ip0enR4FNsFp6fjCV3VsN5FWZQrOgcvub6sG2Gfh4plvVzVTdk8JWfH49PDE99d0-BLSJ5WPoOYLRLg5iE1kSa3IQ6C3EcyK7Q2SkcqZUwZoXRgUhkzqSRLAxZKjWg4JnpGdqq60i8IzYssUTlTeRRDZBMLoYxUSZbLXGpINLVHgi23uHQY5niVxiW3uUzGeMtgDgzmyGB-7ZGP3ZRlC-BxG_EIRaAjROxt-0d9NedOlbnKw0IIFuSpkbEsRBEpGTGd6EwaBQGrR96gAPH2IGtnQfgBxrZZGEeRR95ZCsTfqLDBZy7WTcM_f5_1iD44IlPDO0rhzkvATiFkV49yr0cJBkL2h7eSzJ2Bavg_dfLI224YZ2LTXaXrNdKEEEzmwCuPPG8Fv9uZEOx-CuzzSNpTid7W9Ueq8sLClyeISRdlL29_rFfkfmjVNPOH8R7ZARXQryH-WxUDq-QDsjsaT6azga2iwO9s9OMv4VFgbg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGEIIXxH8CgxkEQkKKlsapkzwgNNZNLdvKNDqpb8axnS7SmpSlBboPxVfgq3HnpGER0t72Wp-t1Pfnd2ef7wh54ysZAVAbN_FC5QY69dxI40lc4sdJ0JUpty-8D4e8fxJ8HnfHa-T36i0MplWubKI11LpQeEa-BY4GB1PKvPjj7LuLXaPwdnXVQqMSi32z_AkhW_lh0AP-vvX9vd3RTt-tuwq4Cnz9ucvBxWASUAk8aZXGFpGxJjtTUWJMqg3TIec6ldp4aagCrrTiocd9ZbB4S8pg3RvkJgCvh8FeOA6bMx2PMYT4-vK0E_GtEoK9CHM7Mccs6LgXLfizXQL-x4JLYNhO1LyEfHv3yN3aZaXblYzdJ2smf0BuVU0slw_Jny-gDeZXnVCb0yKl0-zY9Ts0yymWiaZ4OVDSzB5fmJIWPyA-lziGpWsX54bKXFMEWBQSnAVSWVI8IaYgUtP6jdjSzXINgqibBbScgjWkyZJW-eyAwvSot9ML7IJHo90hnRew3mmWZHM6AVRenBWltN9D5ayYzYsyKx-Rk2th4GOynhe5eUponERdHXMdswA8qUBKnSrdjWIVKwOBrXGIt-KWUHXNdGzdcSZs7BRxUTFYAIMFMlhcOOR9M2VWFQy5ivgTikBDiLW-7Q_F-UTUpkPo2E-k5F4cpipQiUyYVoybrolUqsFBdsgmCpCoHs42Fktsoy8d-QFjDnltKbDeR44JRRO5KEsx-HrcInpXE6UF_Ecl6_cZsFNYIqxFudGiBIOk2sMrSRa1QSzFP_V1yKtmGGdikl9uigXS-OC8xsArhzypBL_ZGR9wJgT2OSRsqURr69ojeXZqy6V3sQYei55d_Vmb5HZ_dHggDgbD_efkjm9VNnI7wQZZB3UwL8D3nCcvrcJT8u26Lcxfsx6ZiQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overexpression+of+miR-21+in+stem+cells+improves+ovarian+structure+and+function+in+rats+with+chemotherapy-induced+ovarian+damage+by+targeting+PDCD4+and+PTEN+to+inhibit+granulosa+cell+apoptosis&rft.jtitle=Stem+cell+research+%26+therapy&rft.au=Fu%2C+Xiafei&rft.au=He%2C+Yuanli&rft.au=Wang%2C+Xuefeng&rft.au=Peng%2C+Dongxian&rft.date=2017-08-14&rft.pub=BioMed+Central+Ltd&rft.issn=1757-6512&rft.eissn=1757-6512&rft.volume=8&rft.issue=1&rft_id=info:doi/10.1186%2Fs13287-017-0641-z&rft.externalDocID=A511282433 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-6512&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-6512&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-6512&client=summon |